| CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation–a target for novel cancer therapy R Tokunaga, WU Zhang, M Naseem, A Puccini, MD Berger, S Soni, ... Cancer treatment reviews 63, 40-47, 2018 | 1068 | 2018 |
| FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor–expressing metastatic colorectal cancer patients treated with single-agent … WU Zhang, M Gordon, AM Schultheis, DY Yang, F Nagashima, M Azuma, ... Journal of clinical oncology 25 (24), 3712-3718, 2007 | 561 | 2007 |
| Primary tumor location as a prognostic factor in metastatic colorectal cancer F Loupakis, D Yang, L Yau, S Feng, C Cremolini, W Zhang, MKH Maus, ... Journal of the National Cancer Institute 107 (3), dju427, 2015 | 532 | 2015 |
| Interleukin‐8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models Y Ning, PC Manegold, YK Hong, W Zhang, A Pohl, G Lurje, T Winder, ... International journal of cancer 128 (9), 2038-2049, 2011 | 528 | 2011 |
| A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer J Stoehlmacher, DJ Park, W Zhang, D Yang, S Groshen, S Zahedy, ... British journal of cancer 91 (2), 344-354, 2004 | 512 | 2004 |
| Association Between Glutathione S-Transferase P1, T1, and M1 Genetic Polymorphism and Survival of Patients With Metastatic Colorectal Cancer J Stoehlmacher, DJ Park, W Zhang, S Groshen, DD Tsao-Wei, MC Yu, ... Journal of the National Cancer Institute 94 (12), 936-942, 2002 | 493 | 2002 |
| A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels MV Mandola, J Stoehlmacher, W Zhang, S Groshen, CY Mimi, S Iqbal, ... Pharmacogenetics and Genomics 14 (5), 319-327, 2004 | 416 | 2004 |
| A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer DJ Park, J Stoehlmacher, W Zhang, DD Tsao-Wei, S Groshen, HJ Lenz Cancer research 61 (24), 8654-8658, 2001 | 407 | 2001 |
| Molecular determinants of cetuximab efficacy D Vallböhmer, W Zhang, M Gordon, DY Yang, J Yun, OA Press, ... Journal of Clinical Oncology 23 (15), 3536-3544, 2005 | 311 | 2005 |
| Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells MA Stanczak, SS Siddiqui, MP Trefny, DS Thommen, KF Boligan, ... The Journal of clinical investigation 128 (11), 4912-4923, 2018 | 239 | 2018 |
| Gender disparities in metastatic colorectal cancer survival A Hendifar, D Yang, F Lenz, G Lurje, A Pohl, C Lenz, Y Ning, W Zhang, ... Clinical Cancer Research 15 (20), 6391-6397, 2009 | 236 | 2009 |
| Cancer dormancy: a model of early dissemination and late cancer recurrence D Páez, MJ Labonte, P Bohanes, W Zhang, L Benhanim, Y Ning, ... Clinical Cancer Research 18 (3), 645-653, 2012 | 227 | 2012 |
| Outlooks on Epstein-Barr virus associated gastric cancer M Naseem, A Barzi, C Brezden-Masley, A Puccini, MD Berger, ... Cancer treatment reviews 66, 15-22, 2018 | 212 | 2018 |
| Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab AM Schultheis, G Lurje, KE Rhodes, W Zhang, D Yang, AA Garcia, ... Clinical Cancer Research 14 (22), 7554-7563, 2008 | 209 | 2008 |
| ERCC1 gene polymorphism as a predictor for clinical outcome in advanced colorectal cancer patients treated with platinum-based chemotherapy. DJ Park, W Zhang, J Stoehlmacher, D Tsao-Wei, S Groshen, J Gil, J Yun, ... Clinical advances in hematology & oncology: H&O 1 (3), 162-166, 2003 | 193 | 2003 |
| A let-7 microRNA-binding site polymorphism in 3′-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with … W Zhang, T Winder, Y Ning, A Pohl, D Yang, M Kahn, G Lurje, MJ Labonte, ... Annals of Oncology 22 (1), 104-109, 2011 | 176 | 2011 |
| B cell and B cell-related pathways for novel cancer treatments R Tokunaga, M Naseem, JH Lo, F Battaglin, S Soni, A Puccini, MD Berger, ... Cancer treatment reviews 73, 10-19, 2019 | 171 | 2019 |
| Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer S Iqbal, B Goldman, CM Fenoglio-Preiser, HJ Lenz, W Zhang, ... Annals of Oncology 22 (12), 2610-2615, 2011 | 170 | 2011 |
| Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer G Lurje, W Zhang, AM Schultheis, D Yang, S Groshen, AE Hendifar, ... Annals of Oncology 19 (10), 1734-1741, 2008 | 160 | 2008 |
| Influence of sex on the survival of patients with esophageal cancer P Bohanes, D Yang, RS Chhibar, MJ Labonte, T Winder, Y Ning, A Gerger, ... Journal of Clinical Oncology 30 (18), 2265-2272, 2012 | 155 | 2012 |
